SearchSearach Website
Close Searach

Search Website

A

Larger Smaller

A

Living Well With Low Vision Sponsored by Prevent Blindness
  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate
Skip to content
Skip to content

Living Well With Low Vision

  • Info & News
  • Clinical Trials
  • Resources
  • Free Books
  • Patients’ Writings
  • About
  • Contact
  • Donate

News & Archive Categories

    Month: February 2019

    First Gene Therapy for AMD Performed

    Posted on February 19, 2019February 23, 2019 by Dan Roberts
  • February 19, 2019

    First Gene Therapy for AMD Performed

    Researchers at the University of Oxford have carried out the world’s first gene therapy operation to tackle the root cause of age-related macular degeneration (AMD). An 80-year-old woman with AMD is the first of ten people to receive the treatment. The procedure was carried out at the John Radcliffe Hospital by Professor Robert MacLaren, Professor […]

      Also posted in
    • Latest News
    • Research and Developments
  • What is Artificial Intelligence and How Can It Help Me?

    Posted on February 18, 2019February 18, 2019 by Dan Roberts
  • February 18, 2019

    What is Artificial Intelligence and How Can It Help Me?

    by Dan Roberts Artificial intelligence (AI) makes it possible for machines to learn from experience, adjust to new inputs, and perform human-like tasks. It provides us with human-like interactions with computers and helps us with difficult decision making. AI works by super-speed processing of large amounts of information (data), allowing the software to learn automatically […]

      Also posted in
    • Daily Living
    • Latest News
  • New Findings in Genetic Pathologies of AMD

    Posted on February 14, 2019October 15, 2019 by Dan Roberts
  • February 14, 2019

    New Findings in Genetic Pathologies of AMD

    With recent successes in gene replacement therapy, scientists are enthused about studying how genetic variants play a part in age-related macular degeneration (AMD).  Previous research has identified 34 small genomic regions (“loci”) on the DNA molecule and 52 genetic variants (mutations) within those loci that are associated with AMD. Variants can regulate certain genes to […]

      Also posted in
    • Latest News
    • Research and Developments
  • Bausch + Lomb Launches New Website to Help People Living With AMD

    Posted on February 5, 2019February 14, 2019 by Dan Roberts
  • February 5, 2019

    Bausch + Lomb Launches New Website to Help People Living With AMD

    New Website offers Patients Comprehensive, Educational Resources to Navigate Life with Age-Related Macular Degeneration Bausch + Lomb, a leading global eye health company, has  announced the launch of SightMatters.com, a new educational online resource for people living with age-related macular degeneration (AMD). Bausch + Lomb launched the site to coincide with the start of AMD […]

      Also posted in
    • Latest News
  • Study Finds That Anti-VEGF Drug Treatments For Wet AMD Do Not Cause Strokes

    Posted on February 2, 2019 by Dan Roberts
  • February 2, 2019

    Study Finds That Anti-VEGF Drug Treatments For Wet AMD Do Not Cause Strokes

    Three anti-VEGF drugs are in clinical use for treatment of wet age-related macular degeneration (wAMD). These are Lucentis (ranibizumab), off-label Avastin (bevacizumab), and Eylea (ranibizumab). The rate of stroke from intravitreal injections of Lucentis was found in the early clinical trials to be 0.2% (1 of 525) in the combined group of patients compared to […]

      Also posted in
    • Latest News
    • Research and Developments
Some Like it Neat, by Alex Vasquez
© All Rights Reserved
Footer Content Right

Receive News and Updates


 

We look to your generosity to support Prevent Blindness and keep our resources up to date.

Donate Now
  • Facebook
  • Twitter
Privacy Policy
Prevent Blindness

© 2018 Prevent Blindness. All rights reserved.